SEC CIK 1131399

GLAXOSMITHKLINE PLC

Reported ownership across 19 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
LYELview stock →30,253,1892021-06-21
WVEview stock →18,245,6912025-12-11
PGNYview stock →6,238,2442020-05-20
GNCAview stock →4,626,3892020-07-24
TBIOview stock →3,697,9122018-07-02
NKTXview stock →3,150,7322020-07-14
PRNBview stock →2,982,8552019-10-18
MORFview stock →2,633,7722019-07-01
TPTXview stock →2,253,6602020-05-21
PANDview stock →2,248,3042020-07-21
SPROview stock →1,934,0062018-07-17
BCYCview stock →1,910,5312020-07-15
FULCview stock →1,785,7142019-07-22
DBTXview stock →1,183,6632021-02-17
CVRXview stock →1,007,5832021-07-02
LQDAview stock →624,4222018-07-30
CCXIview stock →02018-10-16
INVAview stock →02021-05-20
TBPHview stock →02022-09-16

Position History — TBIO

Reported shares owned immediately after each Form 4 transaction, over time.

01,232,6372,465,2753,697,9122018-072018-072018-072018-07

Recent Filings — TBIO

DateActivitySharesPriceOwned After
2018-07-02Conversion (derivative)2,525,253$0.000
2018-07-02Conversion (derivative)7,222,797$0.000
2018-07-02Conversion (derivative)9,300,000$0.000
2018-07-02Open-market buy269,230$13.003,697,912
2018-07-02Conversion454,550—3,428,682
2018-07-02Conversion1,300,116—2,974,132
2018-07-02Conversion1,674,016—1,674,016

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.